Keryx Biopharmaceuticals Inc (KERX)

7.42
0.00 (0.00)
NASDAQ : Health Care
Prev Close 7.42
Open 7.43
Day Low/High 7.38 / 7.51
52 Wk Low/High 2.80 / 9.49
Volume 509.48K
Avg Volume 1.41M
Exchange NASDAQ
Shares Outstanding 105.82M
Market Cap 794.72M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

5 Hot Stocks to Watch Right Now

5 Hot Stocks to Watch Right Now

Biotech stocks continue to dominate our top stock charts to watch.

Keryx Biopharmaceuticals (KERX) Is Weak On High Volume Today

Keryx Biopharmaceuticals (KERX) Is Weak On High Volume Today

Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a weak on high relative volume candidate

'Mad Money' Lightning Round: You're in Good Shape With Charter Communications

'Mad Money' Lightning Round: You're in Good Shape With Charter Communications

Cramer likes Keryx Biopharmaceutical on speculation but is avoiding Synergy Pharmaceuticals.

Jim Cramer's 'Mad Money' Recap: 'Brexit' Is the Dumbest Financial Mistake Ever

Jim Cramer's 'Mad Money' Recap: 'Brexit' Is the Dumbest Financial Mistake Ever

The true cost of British independence from the EU is now becoming apparent, Cramer says.

Keryx Biopharmaceuticals (KERX) Flagged As Strong On High Volume

Keryx Biopharmaceuticals (KERX) Flagged As Strong On High Volume

Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a strong on high relative volume candidate

First Week of KERX December 16th Options Trading

First Week of KERX December 16th Options Trading

Investors in Keryx Biopharmaceuticals Inc. saw new options become available this week, for the December 16th expiration.

Here's a Reason Why Keryx (KERX) Stock Is Spiking Today

Here's a Reason Why Keryx (KERX) Stock Is Spiking Today

Keryx (KERX) stock is surging after Baupost Group increased its stake in the company.

Keryx Biopharmaceuticals (KERX) Is Strong On High Volume Today

Keryx Biopharmaceuticals (KERX) Is Strong On High Volume Today

Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a strong on high relative volume candidate

Biotech Stock Mailbag: Intercept, Acadia, Keryx, Galena

Biotech Stock Mailbag: Intercept, Acadia, Keryx, Galena

TheStreet's Senior Columnist Adam Feuerstein answers reader questions about biotech stock investing.

Keryx Biopharmaceuticals (KERX) In A Perilous Reversal

Keryx Biopharmaceuticals (KERX) In A Perilous Reversal

Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a "perilous reversal" (up big yesterday but down big today) candidate

Keryx Biopharmaceuticals (KERX) Stock Shoots Up on Positive Anemia Drug Results

Keryx Biopharmaceuticals (KERX) Stock Shoots Up on Positive Anemia Drug Results

Keryx Biopharmaceuticals (KERX) stock is skyrocketing on Tuesday after the company announced effective results for its drug treating iron deficiency anemia in chronic kidney disease patients.

Keryx Biopharmaceuticals (KERX) Trading With Heavy Volume Before Market Open

Keryx Biopharmaceuticals (KERX) Trading With Heavy Volume Before Market Open

Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a pre-market mover with heavy volume candidate

Interesting KERX Put And Call Options For May 20th

Interesting KERX Put And Call Options For May 20th

Investors in Keryx Biopharmaceuticals Inc. saw new options become available this week, for the May 20th expiration.

Rockwell Medical's 'Exceptional Year' of Nonexistent Dialysis Drug Sales

Rockwell Medical's 'Exceptional Year' of Nonexistent Dialysis Drug Sales

On Monday night, Rockwell admitted to investors it managed to 'sell' a kidney dialysis product for the last four months of 2015 without actually selling any of the product.

Keryx Biopharmaceuticals (KERX) Weak On High Volume Today

Keryx Biopharmaceuticals (KERX) Weak On High Volume Today

Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a weak on high relative volume candidate

KERX: Insiders vs. Shorts

KERX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 01/15/2016 settlement date, and Keryx Biopharmaceuticals Inc. is one of the most shorted stocks of the Russell 3000, based on 14.41 "days to cover" versus the median component at 4.77.

Will Insiders Be Tempted To Buy More KERX At The New 52-Week Low?

Will Insiders Be Tempted To Buy More KERX At The New 52-Week Low?

In trading on Wednesday, shares of Keryx Biopharmaceuticals Inc. touched a new 52-week low of $2.80/share.

Short Interest Drops 12% For KERX

Short Interest Drops 12% For KERX

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 3,205,482 share decrease in total short interest for Keryx Biopharmaceuticals Inc. , to 23,548,700, a decrease of 11.98% since 12/15/2015.